{"organizations": [], "uuid": "606126d5d080dbce4fb0b1f639e8eecc181d3e05", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180504.html", "section_title": "Archive News &amp; Video for Friday, 04 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-glenmark-pharma-says-co-suspended/brief-glenmark-pharma-says-co-suspended-trial-conducted-at-malpani-hospital-after-alleged-irregularities-idUSFWN1SB131", "country": "US", "domain_rank": 408, "title": "BRIEF-Glenmark Pharma Says Co Suspended Trial Conducted at Malpani Hospital After Alleged Irregularities", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.923, "site_type": "news", "published": "2018-05-04T20:52:00.000+03:00", "replies_count": 0, "uuid": "606126d5d080dbce4fb0b1f639e8eecc181d3e05"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-glenmark-pharma-says-co-suspended/brief-glenmark-pharma-says-co-suspended-trial-conducted-at-malpani-hospital-after-alleged-irregularities-idUSFWN1SB131", "ord_in_thread": 0, "title": "BRIEF-Glenmark Pharma Says Co Suspended Trial Conducted at Malpani Hospital After Alleged Irregularities", "locations": [], "entities": {"persons": [], "locations": [{"name": "malpani hospital", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-glenmark pharma says co suspended trial conducted at malpani hospital", "sentiment": "negative"}, {"name": "glenmark pharmaceuticals ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 4 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* CLARIFIES ON NEWS ITEM ABOUT CO GETTING NOTICE OVER MISCONDUCT IN CLINICAL TRIALS\n* GLENMARK PHARMACEUTICALS - AS SOON AS CO BECAME AWARE OF ALLEGED IRREGULARITIES AT MALPANI HOSPITAL, TRIAL WAS SUSPENDED\n* SAYS CO GOT SHOW CAUSE NOTICE PERTAINING TO MONITORING OF CLINICAL TRIAL AT MALPANI HOSPITAL\n* GLENMARK PHARMACEUTICALS - DEVELOPMENT DOES NOT HAVE MATERIAL IMPACT ON CO Source text - bit.ly/2rkAUzw Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "https://bit.ly/2rkAUzw"], "published": "2018-05-04T20:52:00.000+03:00", "crawled": "2018-05-05T11:56:34.015+03:00", "highlightTitle": ""}